Related Experiment Video
Updated: May 8, 2026

05:16
Multiplexed Fluorescent Immunohistochemical Staining of Four Endometrial Immune Cell Types in Recurrent Miscarriage
Published on: August 4, 2021
3.7K
When Should We Biopsy? A Risk Factor-Based Predictive Model for EIN and Endometrial Cancer
1Department of Obstetrics and Gynecology, Inha University Hospital, Inha University College of Medicine, Incheon 22212, Republic of Korea.
Cancers
|December 11, 2025
Summary
A new clinical model identifies women at risk for endometrial cancer (EC) and endometrial intraepithelial neoplasia (EIN) using six factors. This tool helps guide biopsy decisions, improving early detection and reducing unnecessary procedures for endometrial abnormalities.
Area of Science:
- Gynecology
- Oncology
- Medical Diagnostics
Background:
- Rising global incidence of endometrial cancer (EC) across all age groups.
- Endometrial intraepithelial neoplasia (EIN) is a precursor lesion to EC.
- Need for a clinical model to identify women requiring prompt evaluation for EIN/EC.
Purpose of the Study:
- Develop a multivariable risk prediction model for EIN/EC.
- Guide endometrial biopsy decisions.
- Determine an appropriate BMI cutoff for predicting EIN/EC risk in Asian women.
Main Methods:
- Retrospective review of 1192 women undergoing hysteroscopy (2010-2023).
- Multivariable logistic regression with stepwise selection to identify independent predictors.
- Model stability and calibration assessed using bootstrap resamples.
Main Results:
- Six independent predictors identified: postmenopausal status, abnormal uterine bleeding (AUB), multiple polyps, PCOS, BMI, and endometrial thickness (EMT).
- Obesity (BMI ≥ 30 kg/m²), increased EMT (≥20 mm), and other factors significantly correlated with EIN/EC risk.
- The model demonstrated good discrimination (AUC 0.79) and excellent calibration.
Conclusions:
- A six-factor clinical model effectively stratifies individual EIN/EC risk.
- The model can guide timely, risk-based biopsy decisions, identifying high-risk patients and minimizing unnecessary procedures.
- BMI ≥ 30 kg/m² confirmed as a meaningful cutoff, but external validation is needed.

